Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
European Urology|April 21, 2023
Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell CarcinomaBrittney H Cotta, Toni K Choueiri, Marcin Cieslik, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Evaluating agentic AI for biological discovery in autonomous and copilot settingsShreya Johri, Erica Pimenta, Josephine Yates, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
The GA4GH Categorical Variation Representation Specification: A Unified Computational Framework for Reasoning over Genomic Variant CategoriesDaniel Puthawala, Brendan Reardon, Lawrence Babb, et al.
Biorxiv : the Preprint Server for Biology|December 31, 2025
Mechanisms of tumor persistence in metastatic melanoma following successful immunotherapyYingxiao Shi, Zoltan Maliga, Tuulia Vallius, et al.
Urologic Oncology|November 18, 2023
Anticoagulation prophylaxis patterns following retroperitoneal lymph node dissection for testis cancerVincent D'Andrea, Zhiyu Jason Qian, Kendrick Yim, et al.
JCO Precision Oncology|July 21, 2018
Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid TumorsKelly Klega, Alma Imamovic-Tuco, Gavin Ha, et al.
Cancer Cell|February 11, 2025
Genomic mediators of acquired resistance to immunotherapy in metastatic melanomaJulia Schiantarelli, Mouadh Benamar, Jihye Park, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2023
Clinical Outcomes of De Novo Versus Relapsed Early Metastatic Testicular Seminoma Treated With Contemporary Radiation TherapyDaniel B Rosen, Anushka Ghosh, Andrzej Niemierko, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 28, 2013
A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health recordPeter Tarczy-Hornoch, Laura Amendola, Samuel J Aronson, et al.
Investigational New Drugs|July 1, 2015
Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancerSara M Tolaney, Sally Tan, Hao Guo, et al.
Pageof 6